0	11	thiabendazole	ivermectin	efficacy	Considering 198 patients who concluded follow-up, efficacy was 56.6% for ivermectin and 52.2% for thiabendazole (p = 0.53).
2	13	thiabendazole	ivermectin	efficacy	Considering direct parasitological diagnosis only, efficacy would be 85.7% for ivermectin and 94.6% for thiabendazole (p = 0.21).
3	14	thiabendazole	ivermectin	mild to moderate side effects	In ivermectin arm, mild to moderate side effects were observed in 24/115 patients (20.9%), versus 79/108 (73.1%) in thiabendazole arm (p = 0.00).
4	29	thiabendazole	ivermectin	efficacy	Considering 198 patients who concluded follow-up, efficacy was 56.6% for ivermectin and 52.2% for thiabendazole (p = 0.53).
6	31	thiabendazole	ivermectin	efficacy	Considering direct parasitological diagnosis only, efficacy would be 85.7% for ivermectin and 94.6% for thiabendazole (p = 0.21).
7	32	thiabendazole	ivermectin	mild to moderate side effects	In ivermectin arm, mild to moderate side effects were observed in 24/115 patients (20.9%), versus 79/108 (73.1%) in thiabendazole arm (p = 0.00).
8	135	thiabendazole	ivermectin	Compliance to follow -	Compliance to follow-up was higher for ivermectin (106/115 or 92.2%) than thiabendazole (92/108 or 85.2%), but the difference was not statistically significant (p = 0.15).
9	149	thiabendazole	ivermectin	cured	Based on the primary endpoint (all criteria fulfilled), the subjects cured were 60/106 (56.6%) and 48/92 (52.2%) in ivermectin and thiabendazole arm, respectively (p = 0.53).
10	181	thiabendazole	ivermectin	side effects	In ivermectin arm, side effects were observed in 24/115 patients (20.9%), versus 79/108 (73.1%) in thiabendazole arm (p = 0.00).
